Drugs / HRS5091
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05273775 | Apr → Jun 2022 | chronic hepatitis B virus infection | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT04480294 | Jul 2020 → Nov 2021 | chronic hepatitis B virus infection | Jiangsu HengRui Medicine Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HRS5091 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05273775 ↗ |